MAXCYTE INC
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
MXCT$1.30+3.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
Unaudited Condensed Consolidated Statements of Operations
(in thousands, except share and per share amounts)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, | ||||||
| · 2025 · 2024 | ||||||
| Revenue | | $10,390 | | $11,342 | ||
| Cost of goods sold | | 1,497 | | 1,403 | ||
| Gross profit | | 8,893 | | 9,939 | ||
| | | | | | | |
| Operating expenses: | | | ||||
| Research and development | | 5,903 | | 6,678 | ||
| Sales and marketing | | 5,698 | | 7,365 | ||
| General and administrative | | 8,526 | | 7,103 | ||
| Depreciation and amortization | | | 1,061 | | | 1,068 |
| Total operating expenses | | 21,188 | | 22,214 | ||
| Operating loss | | (12,295) | | (12,275) | ||
| | | | | | | |
| Other income: | | | ||||
| Interest income | | 2,034 | | 2,749 | ||
| Total other income | | 2,034 | | 2,749 | ||
| Loss before income taxes | | | (10,261) | | | (9,526) |
| Provision for income taxes | | | — | | | — |
| Net loss | | $(10,261) | | $(9,526) | ||
| Basic and diluted net loss per share | | $(0.10) | | $(0.09) | ||
| Weighted-average shares outstanding, basic and diluted | | 105,950,480 | | 104,089,758 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.